An alternative synthesis of Azilsartan: an angiotensin II receptor blocker
This paper provides a description of an alternative, novel and commercially viable process which has been developed for the preparation of Azilsartan, a pro-drug of Azilsartan medoxomil, an angiotensin II receptor blocker. The present work also provides a primary account of the synthesis and charact...
Main Authors: | Garaga Srinivas, Misra Nimesh C., Reddy Ambati V. Raghava, Prabahar Koilpillai Joseph, Takshinamoorthy Chandiran, Sanasi Paul Douglas, Korupolu Raghubabu |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2015-06-01
|
Series: | Current Issues in Pharmacy and Medical Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1515/cipms-2015-0047 |
Similar Items
-
Synthesis and characterization of related substances of Azilsartan Kamedoxomil
by: Maddi N. V. D. Harikiran, et al.
Published: (2017-03-01) -
The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders
by: Yu V Zhernakov, et al.
Published: (2014-12-01) -
Full spectrum and genetic algorithm-selected spectrum-based chemometric methods for simultaneous determination of azilsartan medoxomil, chlorthalidone, and azilsartan: Development, validation, and application on commercial dosage form
by: Darwish Hany W., et al.
Published: (2021-03-01) -
Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension
by: Attila Juhasz, et al.
Published: (2018-02-01) -
Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes
by: A. M. Kochergina, et al.
Published: (2023-11-01)